Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 5,700 shares, a growth of 90.0% from the August 15th total of 3,000 shares. Based on an average trading volume of 95,400 shares, the days-to-cover ratio is presently 0.1 days.
Shares of Medexus Pharmaceuticals stock traded down $0.03 on Friday, reaching $2.55. The stock had a trading volume of 7,940 shares, compared to its average volume of 28,361. The business’s 50-day moving average price is $3.99 and its two-hundred day moving average price is $5.31. Medexus Pharmaceuticals has a fifty-two week low of $1.54 and a fifty-two week high of $7.76.
A number of research firms have issued reports on MEDXF. Roth Capital began coverage on shares of Medexus Pharmaceuticals in a research note on Monday, July 19th. They issued a “buy” rating and a $6.15 target price for the company. Canaccord Genuity cut shares of Medexus Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Wednesday, August 18th.
Medexus Pharmaceuticals, Inc operates as a pharmaceutical company, which provides healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The firm products include Rasuvo, Ixinity and Triamcinolone Hexacetonide. The company was founded by Sylvain Chretien in January 2008 and is headquartered in Bolton, Canada.
Featured Story: What is a dead cat bounce?
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.